PMCF Evaluation Report: The PMS-Side Document

This is not the same document as the PMCF plan

There's a persistent mix-up that causes real problems in audits: the PMCF plan and the PMCF evaluation report are treated as a single document, or the report is left vague because teams assume the plan does most of the work. They serve opposite purposes. The plan sits in clinical evaluation — it describes what data you intend to gather and how. The evaluation report sits in PMS — it presents what you actually gathered, what it means, and what changes are warranted as a result. Missing either one, or conflating them, is a recurring Notified Body finding.

Article 61(11) of EU MDR requires manufacturers to document results from PMCF activities in a PMCF evaluation report, which then becomes an integral part of the clinical evaluation report (CER). What this means in practice: the report is generated from PMS activity, but its output feeds directly into your clinical evaluation. It lives at the intersection of both systems, which is exactly why it gets mismanaged.

What the evaluation report must demonstrate

The report should do three things clearly. First, it must summarise the data actually collected through PMCF activities — whether that was a registry, a survey, a literature update, or a clinical investigation. Vague language like "PMCF activities were conducted" without data is not sufficient. The Notified Body will look for actual findings.

Second, the report must evaluate whether those findings change your understanding of the benefit-risk profile of the device. This is the analytical core of the document. If the data confirms what was already known, say so explicitly and explain why. If the data reveals anything unexpected — new adverse event types, a narrower user population than intended, a benefit claim that's harder to substantiate than anticipated — that needs to be stated clearly and linked to corrective action.

Third, the report must conclude whether the PMCF plan itself remains appropriate. If it does, say why. If the data revealed that a particular data source isn't yielding useful signal, or that a new source is needed, this is where you update the plan. The loop from plan to report back to revised plan is what makes PMCF a living system rather than a one-time document.

Common problems with PMCF evaluation reports

One thing that catches a lot of teams off guard: the report is expected to be proportionate to the risk class and complexity of the device, but "proportionate" doesn't mean minimal. For a Class IIb or Class III device, a superficial report that summarises a literature search with no analysis of new findings will not hold up. The Notified Body reviewer will ask: what did you actually learn from your PMCF activity, and how did it change anything?

A second common failure: the report is written at CER renewal time but not linked to the PMS report or PSUR. The three documents — CER, PMCF evaluation report, and PSUR — should reference each other. An auditor tracing a specific adverse event finding should be able to move from the PSUR, where it was first flagged, into the PMCF evaluation report, where it was investigated, and into the CER, where the benefit-risk conclusion was updated. If that chain breaks, it's a finding.

A third issue is timing. PMCF evaluation reports must be updated whenever the PMCF plan produces new data. For devices under periodic review — annual PSUR or multi-year PMSR — this means the report frequency should be aligned to PMS review cycles, not to the CER review cycle independently.

Where the PMCF evaluation report connects in your system

The report is explicitly listed in Annex XIV, Part B of MDR as a required output. It must be included in your technical documentation and referenced in your CER. When Notified Bodies conduct Article 61 assessments, the absence of a current PMCF evaluation report — not just a plan — is a non-conformity.

For manufacturers still running PMCF under a plan that was designed pre-MDR or during early transition: check whether your evaluation report actually analyses the data your plan committed to collecting, or whether it's essentially a restatement of the plan. That restatement pattern is one of the most common gaps seen in MDR conformity audits.

Where to go from here

If you are building or updating your PMCF system, start by separating the plan and the report into distinct documents with distinct purposes, then ensure the report contains actual data findings and a benefit-risk assessment — not just a summary of planned activities. The PMS plan structure resource in this category covers how your overall PMS system should be organised. The clinical evaluation category covers what the CER needs to incorporate from the PMCF evaluation report.